abstract |
Compounds, pharmaceutical compositions, and related methods for treating viral infections in individuals, including RNA viral infections, are disclosed herein. Such compounds, pharmaceutical compositions and methods can modulate innate immune antiviral responses in vertebrate cells, including activation of the RIG-I pathway. |